Previous Close | 8.25 |
Open | 8.15 |
Bid | 7.92 x 100 |
Ask | 8.00 x 100 |
Day's Range | 7.94 - 8.31 |
52 Week Range | 7.72 - 27.48 |
Volume | |
Avg. Volume | 1,080,779 |
Market Cap | 1.075B |
Beta (5Y Monthly) | 0.41 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Vir Biotechnology Inc (NASDAQ:VIR), a company focused on the research and development of treatments for serious infectious diseases, has reported an insider sell according to a recent SEC filing.
Q4 2023 Vir Biotechnology Inc Earnings Call
Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript February 22, 2024 Vir Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.86, expectations were $-1.14. Vir Biotechnology, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello. Welcome to Vir […]